#alnylam — Public Fediverse posts

Novo kidney trial finds Ozempic cuts cardiac risks in diabetics—Bayer CEO launches ‘full-scale effort’ to rejuvenate pharma pipeline, tables split-up but warns not never—Roche, Alnylam say blood pressure drug succeeds in mid-stage trial--http://bit.ly/w28kSd #novonordisk #ozempic #diabetes #bayer #clinicaltrials #ceos #hypertension #roche #alnylam #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

Does anyone have any rational explanation for why the US filed a § 1498 statement-of-interest in the #Moderna v. #Arbutus case but NOT the #Moderna v. #Alnylam case?
#patents